1. Home
  2. KRNT vs NVAX Comparison

KRNT vs NVAX Comparison

Compare KRNT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNT
  • NVAX
  • Stock Information
  • Founded
  • KRNT 2002
  • NVAX 1987
  • Country
  • KRNT Israel
  • NVAX United States
  • Employees
  • KRNT N/A
  • NVAX N/A
  • Industry
  • KRNT Industrial Machinery/Components
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KRNT Industrials
  • NVAX Health Care
  • Exchange
  • KRNT Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • KRNT 1.4B
  • NVAX 1.3B
  • IPO Year
  • KRNT 2015
  • NVAX 1995
  • Fundamental
  • Price
  • KRNT $21.34
  • NVAX $8.10
  • Analyst Decision
  • KRNT Strong Buy
  • NVAX Buy
  • Analyst Count
  • KRNT 5
  • NVAX 6
  • Target Price
  • KRNT $34.00
  • NVAX $17.83
  • AVG Volume (30 Days)
  • KRNT 374.7K
  • NVAX 4.7M
  • Earning Date
  • KRNT 05-07-2025
  • NVAX 05-09-2025
  • Dividend Yield
  • KRNT N/A
  • NVAX N/A
  • EPS Growth
  • KRNT N/A
  • NVAX N/A
  • EPS
  • KRNT N/A
  • NVAX N/A
  • Revenue
  • KRNT $203,825,000.00
  • NVAX $682,162,000.00
  • Revenue This Year
  • KRNT $11.22
  • NVAX N/A
  • Revenue Next Year
  • KRNT $12.76
  • NVAX $15.02
  • P/E Ratio
  • KRNT N/A
  • NVAX N/A
  • Revenue Growth
  • KRNT N/A
  • NVAX N/A
  • 52 Week Low
  • KRNT $13.59
  • NVAX $3.81
  • 52 Week High
  • KRNT $34.29
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • KRNT 26.01
  • NVAX 50.36
  • Support Level
  • KRNT $19.53
  • NVAX $7.66
  • Resistance Level
  • KRNT $23.88
  • NVAX $8.48
  • Average True Range (ATR)
  • KRNT 1.30
  • NVAX 0.66
  • MACD
  • KRNT -0.27
  • NVAX 0.08
  • Stochastic Oscillator
  • KRNT 27.34
  • NVAX 67.08

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: